Hirofumi Suwa
Amagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry.
Journal: Breast (Edinburgh, Scotland)
Published: January 30, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancer.
Journal: Endocrine-related cancer
Published: December 26, 2024
Association Between Treated Periodontal Disease and Febrile Neutropenia in Perioperative Chemotherapy for Breast Cancer: A Retrospective Cohort Study.
Journal: Cureus
Published: December 30, 2023
Half Dose Pegfilgrastim for Patients With Breast Cancer During Chemotherapy: A Case-series.
Journal: Anticancer research
Published: December 30, 2022
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study.
Journal: Breast cancer (Tokyo, Japan)
Published: May 23, 2022
Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer.
Journal: Scientific reports
Published: March 11, 2022
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study.
Journal: Breast cancer (Tokyo, Japan)
Published: January 19, 2022
Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan-The KBCOG-14 Study.
Journal: Breast cancer : basic and clinical research
Published: September 17, 2020
Last Updated: 09/26/2026